Mantenimiento de la Estimulación Cerebral No Invasiva para Prevenir la Recaída en la Depresión: Una Revisión...

Depression relapse rates remain high after acute treatment; this study evaluates the efficacy of maintenance noninvasive brain stimulation in preventing relapse and identifies optimal treatment parameters.

This meta-analysis was conducted following PRISMA guidelines. We conducted a systematic search of PubMed, Embase, Web of Science, Cochrane Library, and PsycINFO databases up to January 5, 2025. The primary outcome was relapse rate.

A total of nine randomized controlled trials with 837 participants were included, six studies used electroconvulsive therapy (ECT) and three studies used repetitive transcranial magnetic stimulation (rTMS). Our findings indicate that ECT combined with pharmacotherapy or rTMS alone demonstrated superiority over pharmacotherapy alone in reducing the relapse of depression during 6, 9, 12-month maintenance treatment periods. Interestingly, ECT alone did not show significant results. In terms of stimulation parameters, the ECT combined with pharmacotherapy group mainly received right unilateral stimulation, while the ECT alone group had bitemporal stimulation. The stimulation frequency was similar between the two groups. In contrast, the rTMS-alone group had significantly higher stimulation frequencies than the ECT groups. We did not find any eligible studies on transcranial direct current stimulation, transcranial alternating current stimulation or magnetic seizure therapy, but they also showed potential in the maintenance treatment of depression, which warrants further investigation.

ECT combined with pharmacotherapy, or rTMS alone, is more effective than pharmacotherapy alone in preventing relapse of depression during 6 to 12 months of maintenance treatment. Future research should prioritize identifying the optimal treatment regimen and exploring the potential of combination therapies.

CRD42023490546, https://www.crd.york.ac.uk/PROSPERO/view/CRD42023490546.